Shares of Tempus AI jumped over 7% Wednesday to reach an all-time high of $99.90. Shares of the AI medical diagnostics company are up over 191% for the year so far.
The company has recently announced a flurry of FDA clearances for its technologies. Most recently, on September 22, Tempus AI was granted FDA clearance for its Tempus xR IVD device, which is used to tailor cancer therapies.
Shares of crypto miner and AI compute provider IREN dropped after the Australia-based, US-listed company said late Tuesday that it would sell $875 million in convertible senior debt.
The announcement came late in the trading day and caused a sell-off in the aftermarket session that continued into Wednesday trading.
The offering makes sense; the company can probably get some fairly cheap capital after its shares doubled over the last month.
But it exposes shareholders to some dilution risk if buyers of the hybrid securities do convert them into equity, which explains the market reaction.
The offering makes sense; the company can probably get some fairly cheap capital after its shares doubled over the last month.
But it exposes shareholders to some dilution risk if buyers of the hybrid securities do convert them into equity, which explains the market reaction.
The precious metal is soaring in value.
Satellite operator AST SpaceMobile rocketed in early trading after announcing a deal with Verizon in which the telecom giant will use AST’s satellites to provide cellular broadband service “when needed for Verizon customers starting in 2026.”
The market seems to view the announcement as a vote of confidence for the recent romp of services-from-space stocks. Planet Labs and Rocket Lab, which also announced a deal for three new launches on Tuesday afternoon, were both up sharply in early trading.
